Peregrine Capital Management LLC Natera, Inc. Transaction History

Peregrine Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 12, 2019	SELL	$11.34 - $20.62 $6.05 Million - $11 Million	-533,483 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$12.32 - $24.38 $30,430 - $60,218	-2,470 Reduced 0.46%	533,483 $7.45 Million
Q3 2018 Oct 18, 2018	BUY	$18.82 - $28.96 $10.1 Million - $15.5 Million	535,953 New	535,953 $0

440

117M

254K

263K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.